ОПЫТ ПРИМЕНЕНИЯ МОКСОНИДИНА У БОЛЬНЫХ МЕТАБОЛИЧЕСКИМ СИНДРОМОМ
Published in HYPERTENSION • Feb 28, 2015
NobleIDNI9P46W48R85S60
Authors:,,
Е. А. Чубенко
О. Д. Беляева
E. Bazhenova
Abstract
Objective. Imidazoline receptor agonist moxonidine besides antihypertensive effect can increase insulin sensitivity, reduce leptin level, and improve lipid metabolism. However, the efficacy, tolerability and pleiotropic effects of moxonidine in postmenopausal women with essential hypertension (EH) a...
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!